FDA Resists Push For Longer Rulemaking Route On Lab-Developed Tests

FDA hopes to get a proposed regulatory framework for lab-developed tests out the door within a matter of months, but lab groups and other stakeholders are saying: slow down

More from Archive

More from Medtech Insight